VCI Global (Nasdaq: VCIG) resets warrant share count after 2026 reverse splits

Rhea-AI Filing Summary

VCI Global Ltd (VCIG) filed a prospectus supplement reducing the securities covered under its January 2026 prospectus supplement to 63,986 Ordinary Shares. These consist of 9,526 Ordinary Shares issued (including upon exercise of Pre-Funded Warrants) and 54,460 Ordinary Shares issued upon exercise of Common A Warrants.

All Ordinary Shares covered have been sold and issued. The share numbers reflect a 1-for-60 reverse stock split on February 27, 2026 and a 1-for-15 reverse stock split on August 24, 2026. VCIG’s Ordinary Shares trade on Nasdaq under “VCIG,” with a last reported sale price of $0.2129 on August 21, 2026. The company highlights significant risk factors and its status as an emerging growth company and foreign private issuer.

Key Figures

Ordinary Shares covered: 63,986 Ordinary Shares Ordinary Shares issued (including upon exercise of Pre-Funded Warrants): 9,526 Ordinary Shares Ordinary Shares issued upon exercise of Common A Warrants: 54,460 Ordinary Shares +3 more

6 metrics

Ordinary Shares covered 63,986 Ordinary Shares Total Ordinary Shares covered by this prospectus supplement

Ordinary Shares issued (including upon exercise of Pre-Funded Warrants) 9,526 Ordinary Shares Portion of the 63,986 shares related to Ordinary Shares and exercised Pre-Funded Warrants

Ordinary Shares issued upon exercise of Common A Warrants 54,460 Ordinary Shares Portion of the 63,986 shares from exercised Common A Warrants

Reverse stock split ratio 1-for-60 Reverse stock split of Ordinary Shares effective February 27, 2026

Reverse stock split ratio 1-for-15 Reverse stock split of Ordinary Shares effective August 24, 2026

Last reported sale price $0.2129 per share Nasdaq price for Ordinary Shares on August 21, 2026

Key Terms

Prospectus Supplement, Pre-Funded Warrants, Common A Warrants, Common B Warrants, +2 more

6 terms

Prospectus Supplement regulatory

"This prospectus supplement (the “Prospectus Supplement”) amends and supplements"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Pre-Funded Warrants financial

"pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 35,722"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

Common A Warrants financial

"Common A Warrants (the “Common A Warrants”) to purchase 71,445 Ordinary"

Common B Warrants financial

"Common B Warrants (the “Common B Warrants” and together with the"

reverse stock split financial

"gives effect to (i) the 1-for-60 reverse stock split of the Company's"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

emerging growth company regulatory

"We are an “emerging growth company,” as that term is defined"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Offering Details

shelf

Offering

Offering Type shelf

FAQ

What does VCI Global Ltd (VCIG) change in this August 2026 prospectus supplement?

The supplement reduces the January 2026 offering coverage to 63,986 Ordinary Shares, made up of 9,526 shares issued (including via Pre-Funded Warrants) and 54,460 shares issued upon exercise of Common A Warrants. All these shares have already been sold and issued.

How many VCI Global Ltd (VCIG) shares were tied to Pre-Funded and Common A Warrants?

The supplement covers 9,526 Ordinary Shares issued (including upon exercise of Pre-Funded Warrants) and 54,460 Ordinary Shares issued upon exercise of Common A Warrants, for a total of 63,986 Ordinary Shares now covered.

Have all the VCIG shares covered by this supplement already been issued?

Yes. The company states that all 63,986 Ordinary Shares covered by this prospectus supplement have been sold and issued as of the supplement date.

What reverse stock splits has VCI Global Ltd (VCIG) effected in 2026?

The company effected a 1-for-60 reverse stock split of its Ordinary Shares on February 27, 2026 and a 1-for-15 reverse stock split on August 24, 2026. The share counts in the supplement give effect to both splits.

What was the recent Nasdaq trading price of VCI Global Ltd (VCIG) shares?

On August 21, 2026, the last reported sale price of VCI Global Ltd’s Ordinary Shares on Nasdaq was $0.2129 per share.

What regulatory status does VCI Global Ltd (VCIG) claim in this supplement?

VCI Global Ltd states it is an “emerging growth company” and a foreign private issuer, which allows it to follow certain reduced public company reporting requirements under U.S. federal securities laws.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 06:01 AM Accepted by SEC EDGAR 08/24/2026 - 05:44 PM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5)

Registration Statement No. 333-279521

Prospectus Supplement

(To Prospectus dated May 28, 2024)

63,986 Ordinary Shares

This prospectus supplement (the “Prospectus Supplement”) amends and supplements the prospectus supplement dated January 21, 2026 (the “January 2026 Prospectus Supplement”) to reduce the securities covered thereby. The January 2026 Prospectus Supplement related to the offering of (i) 35,722 of our ordinary shares, no par value per share (the “Ordinary Shares”), (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 35,722 of our Ordinary Shares, (iii) Common A Warrants (the “Common A Warrants”) to purchase 71,445 Ordinary Shares and (iv) Common B Warrants (the “Common B Warrants” and together with the Common A Warrants, the “Common Warrants”) to purchase 71,445 Ordinary Shares (collectively, the “Offered Securities”), directly to a single institutional investor (the “Investor”) pursuant to a securities purchase agreement dated January 20, 2026 (the “Securities Purchase Agreement”).

We are filing this Prospectus Supplement to reduce the January 2026 Prospectus Supplement to cover the Offered Securities to 63,986 Ordinary Shares, consisting of (i) 9,526 Ordinary Shares issued (including upon exercise of Pre-Funded Warrants) and (ii) 54,460 Ordinary Shares issued upon exercise of Common A Warrants. All the Ordinary Shares covered by this Prospectus Supplement have been sold and issued as of the date of this Prospectus Supplement.

The number of Ordinary Shares referenced in this Prospectus Supplement gives effect to (i) the 1-for-60 reverse stock split of the Company's Ordinary Shares effected on February 27, 2026 and (ii) the 1-for-15 reverse stock split of the Company's Ordinary Shares effected on August 24, 2026.

Our Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbols “VCIG.” On August 21, 2026, the last reported sale price of our ordinary shares on Nasdaq was $0.2129 per share.

Investing in our securities involves a high degree of risk. See “Risk Factors” section beginning on page S-11 of the January 2026 Prospectus Supplement.

We are an “emerging growth company,” as that term is defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements and may elect to do so in future filings. See the sections entitled “Prospectus Supplement Summary—Implications of Being an Emerging Growth Company” and “Prospectus Supplement Summary—Implications of Our Foreign Private Issuers Status” for additional information.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is August 24, 2026